本文選題：惡性胸腔積液　切入點(diǎn)：白介素-　出處：《實(shí)用中醫(yī)藥雜志》2011年01期

【摘要】：目的:觀察胸腔引流后腔內(nèi)注入白介素-2聯(lián)合中藥湯劑治療惡性胸腔積液的療效及毒副反應(yīng)。方法:觀察組15例與對(duì)照組15例均用中心靜脈導(dǎo)管進(jìn)行胸腔閉式引流,待胸腔積液引流徹底后胸腔內(nèi)給白介素-2,觀察組另服葶藶大棗瀉肺湯加減。結(jié)果:有效率觀察組73.3%、對(duì)照組60.0%,觀察組療效明顯優(yōu)于對(duì)照組(P0.05),且臨床癥狀改善明顯,兩組均未出現(xiàn)嚴(yán)重毒副反應(yīng)。結(jié)論:中西醫(yī)結(jié)合治療惡性胸腔積液療效好,可有效改善患者生存質(zhì)量,延長(zhǎng)患者生存時(shí)間。
[Abstract]:Objective: to observe the curative effect and side effects of intraluminal injection of interleukin-2 and traditional Chinese medicine decoction on malignant pleural effusion after thoracic drainage. Methods: 15 cases in the observation group and 15 cases in the control group were treated with central venous catheter for thoracic closed drainage. Results: the effective rate was 73.3 in the observation group and 60.0in the control group. The curative effect of the observation group was obviously better than that of the control group (P 0.05), and the clinical symptoms were improved obviously. Conclusion: the treatment of malignant pleural effusion with combination of traditional Chinese and western medicine has a good effect and can effectively improve the quality of life of patients and prolong the survival time of patients.
【作者單位】： 遼寧省本溪市中心醫(yī)院中西醫(yī)結(jié)合病房;
【分類號(hào)】：R730.5

【共引文獻(xiàn)】

相關(guān)期刊論文 前10條

1 鐘毅,周紅,張衛(wèi)萍,江俊珊;中醫(yī)辨證論治癌痛54例[J];安徽中醫(yī)臨床雜志;2001年06期

2 施琴;針刺足三里、內(nèi)關(guān)穴預(yù)防化療胃腸道反應(yīng)療效觀察[J];中醫(yī)藥臨床雜志;2004年05期

3 賈英杰,賈彥燾,陳軍;愛迪注射液聯(lián)合化療治療非小細(xì)胞肺癌臨床研究[J];中醫(yī)藥臨床雜志;2005年01期

4 石璐,陳軍剛,嚴(yán)嘯薇;黃芪注射液對(duì)含阿霉素方案化療毒副反應(yīng)的影響[J];中醫(yī)藥臨床雜志;2005年01期

5 付文勝;四君子湯提高晚期惡性腫瘤病人生活質(zhì)量療效觀察[J];中醫(yī)藥臨床雜志;2005年01期

6 惠錦林;阿霉素持續(xù)輸注加時(shí)辰化療為主的CHOP方案治療惡性淋巴瘤[J];安徽醫(yī)學(xué);2005年01期

7 潘明,劉飛,徐金發(fā),宋文燦,劉春林,陳國(guó)卿;化療加放射治療晚期鼻咽癌的臨床分析[J];安徽醫(yī)藥;2005年05期

8 李瑾,俞超芹,陳U，

本文編號(hào)：1667395